Respiratory News and Research

RSS

Study finds shared genetic risk variants across different substance use disorders

By combing through genomic data of over 1 million people, scientists have identified genes commonly inherited across addiction disorders, regardless of the substance being used.

22 Mar 2023

Bedfont’s NObreath® monitor for airway inflammation has been cleared for sale in the USA

Bedfont’s NObreath® monitor for airway inflammation has been cleared for sale in the USA.

From NObreath 22 Mar 2023

Low-cost, universal oral COVID-19 vaccine prevents severe respiratory illness in hamsters

A UCLA-led team has developed an inexpensive, universal oral COVID-19 vaccine that prevented severe respiratory illness and weight loss when tested in hamsters, which are naturally susceptible to SARS-CoV-2.

22 Mar 2023

New study investigates effect of short-term PM2.5 exposure on blood lipids

A recent Scientific Reports study sought to address a gap in research and determined the association between short-term PM2.5 exposure and blood lipids.

22 Mar 2023

Tetravalent COVID vaccine provides broad antibody responses against SARS-CoV-2 variants in animal model

In a recent study posted to the bioRxiv* preprint server, researchers in Italy and the United States evaluated the efficacy and immunogenicity of an adjuvanted tetravalent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) protein subunit 1 (S1) COVID-19 vaccine.

21 Mar 2023

Prior COVID and vaccination generate superior hybrid immunity

In a recent article published in the journal Science Translational Medicine, researchers in France performed a long-term longitudinal analysis to demonstrate the benefits of hybrid immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), i.e., induced by viral infection followed by vaccination.

21 Mar 2023

Loss of smell following COVID-19 recovery: How long could it last?

In a recent study posted to the Preprints with The Lancet* server, researchers in China conducted a multi-center, retrospective study to gather data on the prevalence of olfactory dysfunction (OD) after three years of recovering from coronavirus disease 2019 (COVID-19).

21 Mar 2023

Paxlovid is 80% effective when taken within 5 days of severe COVID

In a recent study published in The Lancet’s Infectious Diseases, researchers in the United States evaluated nirmatrelvir–ritonavir treatment effectiveness against hospitalizations and deaths among coronavirus disease 2019 (COVID-19) outpatients in the United States of America (USA).

21 Mar 2023

Next-gen Mpro inhibitor: Promising new drug candidate against Omicron and other SARS-CoV-2 variants

A recent Nature Signal Transduction and Targeted Therapy journal study demonstrated the potential antiviral activity of a new Mpro inhibitor (SY110) against SARS-CoV-2 Omicron and its sublineages.

21 Mar 2023

The effectiveness of mRNA vaccines during Omicron BA.4/5 predominance

Researchers evaluate vaccine effectiveness for two, three, and four doses of COVID-19 mRNA first-generation vaccines.

21 Mar 2023

Co-infection with MRSA ‘superbug’ could make COVID-19 outcomes even more deadly

Global data shows nearly 10 per cent of severe COVID-19 cases involve a secondary bacterial co-infection – with Staphylococcus aureus, also known as Staph A., being the most common organism responsible for co-existing infections with SARS-CoV-2.

21 Mar 2023

Study suggests saliva samples may be better indicators of SARS-CoV-2 persistence than nasal swabs

In a recent study published in the PLOS ONE journal, researchers at Rutgers New Jersey Medical School explored the persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human saliva.

21 Mar 2023

Study provides insights on stability of SARS-CoV-2 in biological fluids of animals

In a recent study published in the Viruses journal, researchers assessed the stability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among biological fluids found in animals.

21 Mar 2023

Discovery of 16th century coronavirus in France

In a recent study published in the International Journal of Infectious Diseases, researchers conducted paleoserological tests on dental pulp samples of skeletons excavated from the Abbey Saint-Pierre in the village of Baume-Les-Messieurs in France.

20 Mar 2023

Childhood common colds help protect against COVID-19

In a recent study published in the Proceedings of the National Academy of Sciences, researchers assessed the association between cross-reactive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) CD4+ T cells generation and age.

20 Mar 2023

Research reports spillover of highly pathogenic avian influenza A(H5N1) into marine mammals in the northeastern United States

A recent study published in the United States (U.S.) Centers for Disease Control and Prevention (CDC) journal Emerging Infectious Diseases reported the outbreak of the highly pathogenic hemagglutinin type 5 and neuraminidase type 1 (H5N1) avian influenza virus among New England gray and harbor seals in the United States (U.S.)

20 Mar 2023

Respiratory News and Research

Study finds shared genetic risk variants across different substance use disorders

Bedfont’s NObreath® monitor for airway inflammation has been cleared for sale in the USA

Low-cost, universal oral COVID-19 vaccine prevents severe respiratory illness in hamsters

New study investigates effect of short-term PM2.5 exposure on blood lipids

Tetravalent COVID vaccine provides broad antibody responses against SARS-CoV-2 variants in animal model

Prior COVID and vaccination generate superior hybrid immunity

Loss of smell following COVID-19 recovery: How long could it last?

Paxlovid is 80% effective when taken within 5 days of severe COVID

Next-gen Mpro inhibitor: Promising new drug candidate against Omicron and other SARS-CoV-2 variants

The effectiveness of mRNA vaccines during Omicron BA.4/5 predominance

Co-infection with MRSA ‘superbug’ could make COVID-19 outcomes even more deadly

Study suggests saliva samples may be better indicators of SARS-CoV-2 persistence than nasal swabs

Study provides insights on stability of SARS-CoV-2 in biological fluids of animals

Discovery of 16th century coronavirus in France

Childhood common colds help protect against COVID-19

Research reports spillover of highly pathogenic avian influenza A(H5N1) into marine mammals in the northeastern United States

Elevated mucosal immune response expedites COVID-19 recovery

RSV causes 160,000 hospitalizations every year in the EU, according to new study

The impact of long-COVID on professional soccer

Poor inflammatory immune response in obese patients increases susceptibility to severe COVID-19

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News